Use of sevelamer in chronic kidney disease: beyond phosphorus control

Statistics

Review article

Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo

Laura Rodríguez-Osorioa, Diana Pazmiño Zambranoa, Carolina Gracia-Iguacela, Jorge Rojas-Riveraa, Alberto Ortizb, Jesus Egidob, Emilio González Parrac,

Corresponding author

egparra@fjd.es

Corresponding author. Emilio González Parra, Division of Nephrology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Av Reyes Católicos 2, Madrid, Madrid, Spain. Tel.: +915504800.

a Division of Nephrology, Fundación Jiménez Díaz [Jiménez Díaz Foundation], Madrid, Madrid (Spain)

b Division of Nephrology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid [Autonomous University of Madrid], Madrid, Madrid (Spain)

c Division of Nephrology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Madrid (Spain)

Read

13705

Times
was read the article

2921

Total PDF

10784

Total HTML

Share statistics

Article information

ISSN: 20132514
Original language: English

DOI:10.1016/j.nefroe.2015.05.011

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	159	36	195
2025 5	286	38	324
2025 4	205	26	231
2025 3	211	67	278
2025 2	146	30	176
2025 1	146	49	195
2024 12	81	29	110
2024 11	90	46	136
2024 10	83	28	111
2024 9	76	20	96
2024 8	79	56	135
2024 7	81	26	107
2024 6	62	35	97
2024 5	63	44	107
2024 4	107	41	148
2024 3	66	24	90
2024 2	54	49	103
2024 1	42	24	66
2023 12	42	19	61
2023 11	70	33	103
2023 10	63	34	97
2023 9	67	23	90
2023 8	43	26	69
2023 7	65	22	87
2023 6	46	25	71
2023 5	82	36	118
2023 4	56	23	79
2023 3	85	25	110
2023 2	50	13	63
2023 1	63	39	102
2022 12	86	19	105
2022 11	71	31	102
2022 10	64	36	100
2022 9	47	28	75
2022 8	49	46	95
2022 7	46	51	97
2022 6	45	35	80
2022 5	44	32	76
2022 4	66	42	108
2022 3	100	67	167
2022 2	97	46	143
2022 1	105	38	143
2021 12	77	39	116
2021 11	76	32	108
2021 10	55	53	108
2021 9	40	38	78
2021 8	47	40	87
2021 7	52	36	88
2021 6	61	43	104
2021 5	58	31	89
2021 4	140	29	169
2021 3	64	30	94
2021 2	43	19	62
2021 1	38	18	56
2020 12	44	11	55
2020 11	57	14	71
2020 10	26	10	36
2020 9	36	15	51
2020 8	39	10	49
2020 7	49	18	67
2020 6	43	19	62
2020 5	63	12	75
2020 4	60	26	86
2020 3	48	23	71
2020 2	47	30	77
2020 1	79	27	106
2019 12	84	44	128
2019 11	51	26	77
2019 10	57	22	79
2019 9	69	38	107
2019 8	50	17	67
2019 7	63	31	94
2019 6	57	18	75
2019 5	63	22	85
2019 4	104	21	125
2019 3	54	33	87
2019 2	33	21	54
2019 1	59	17	76
2018 12	320	52	372
2018 11	652	30	682
2018 10	262	32	294
2018 9	101	19	120
2018 8	62	19	81
2018 7	70	16	86
2018 6	56	11	67
2018 5	79	16	95
2018 4	65	9	74
2018 3	53	10	63
2018 2	61	11	72
2018 1	30	8	38
2017 12	50	6	56
2017 11	54	14	68
2017 10	53	17	70
2017 9	64	11	75
2017 8	61	7	68
2017 7	61	20	81
2017 6	80	15	95
2017 5	112	12	124
2017 4	72	12	84
2017 3	76	9	85
2017 2	114	7	121
2017 1	49	18	67
2016 12	80	10	90
2016 11	131	28	159
2016 10	157	15	172
2016 9	248	3	251
2016 8	259	8	267
2016 7	231	19	250
2016 6	175	0	175
2016 5	181	0	181
2016 4	181	0	181
2016 3	142	0	142
2016 2	151	0	151
2016 1	131	0	131
2015 12	119	21	140
2015 11	105	17	122
2015 10	106	15	121
2015 9	53	12	65
2015 8	1	1	2
2015 5	1	1	2

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter